| abstract |
Novel oxadiazole compounds, pharmaceutical compositions containing such compounds and the S1P G protein-coupled receptor for treating diseases associated with modulation of S1P family receptor activity by providing particularly beneficial immunosuppressive effects The use of those compounds or compositions as family agonists or antagonists is disclosed. |